Build Your Comparison

Side-by-side financial analysis
NGVT logo
NGVT
KWR logo
KWR
CBT logo
CBT
FUL logo
FUL
Try popular comparisons:

Stock Comparison

NGVT vs KWR vs CBT vs FUL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NGVT
Ingevity Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$2.54B
5Y Perf.+36.9%
KWR
Quaker Chemical Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$2.50B
5Y Perf.-22.2%
CBT
Cabot Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$4.58B
5Y Perf.+136.6%
FUL
H.B. Fuller Company

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$3.45B
5Y Perf.+42.7%

NGVT vs KWR vs CBT vs FUL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NGVT logoNGVT
KWR logoKWR
CBT logoCBT
FUL logoFUL
IndustryChemicals - SpecialtyChemicals - SpecialtyChemicals - SpecialtyChemicals - Specialty
Market Cap$2.54B$2.50B$4.58B$3.45B
Revenue (TTM)$1.21B$1.93B$3.58B$3.47B
Net Income (TTM)$-128M$4M$285M$152M
Gross Margin39.3%34.4%24.8%31.5%
Operating Margin22.8%3.7%15.7%10.9%
Forward P/E14.6x20.6x13.9x13.5x
Total Debt$1.24B$929M$1.22B$2.02B
Cash & Equiv.$78M$180M$258M$107M

NGVT vs KWR vs CBT vs FULLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NGVT
KWR
CBT
FUL
StockJun 20Jun 26Return
Ingevity Corporation (NGVT)100136.9+36.9%
Quaker Chemical Cor… (KWR)10077.8-22.2%
Cabot Corporation (CBT)100236.6+136.6%
H.B. Fuller Company (FUL)100142.7+42.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: NGVT vs KWR vs CBT vs FUL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CBT leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Ingevity Corporation is the stronger pick specifically for recent price momentum and sentiment. KWR and FUL also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
🥇CBT emerged as the overall leader. Track its performance:
NGVT
Ingevity Corporation
The Momentum Pick

NGVT is the #2 pick in this set and the best alternative if momentum is your priority.

  • +66.6% vs FUL's +15.2%
Best for: momentum
KWR
Quaker Chemical Corporation
The Growth Play

KWR is the clearest fit if your priority is growth exposure.

  • Rev growth 2.7%, EPS growth -102.2%, 3Y rev CAGR -1.0%
  • 2.7% revenue growth vs NGVT's -17.0%
Best for: growth exposure
CBT
Cabot Corporation
The Income Pick

CBT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 14 yrs, beta 0.82, yield 2.0%
  • 119.6% 10Y total return vs NGVT's 111.0%
  • Lower volatility, beta 0.82, Low D/E 71.3%, current ratio 1.61x
  • Beta 0.82, yield 2.0%, current ratio 1.61x
Best for: income & stability and long-term compounding
FUL
H.B. Fuller Company
The Value Play

FUL is the clearest fit if your priority is value.

  • Lower P/E (13.5x vs 13.9x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthKWR logoKWR2.7% revenue growth vs NGVT's -17.0%
ValueFUL logoFULLower P/E (13.5x vs 13.9x)
Quality / MarginsCBT logoCBT8.0% margin vs NGVT's -10.6%
Stability / SafetyCBT logoCBTBeta 0.82 vs KWR's 1.36
DividendsCBT logoCBT2.0% yield, 14-year raise streak, vs FUL's 1.4%, (1 stock pays no dividend)
Momentum (1Y)NGVT logoNGVT+66.6% vs FUL's +15.2%
Efficiency (ROA)CBT logoCBT7.4% ROA vs NGVT's -7.3%, ROIC 17.4% vs 14.2%

NGVT vs KWR vs CBT vs FUL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NGVTIngevity Corporation
FY 2025
Performance Materials
60.2%$607M
Performance Chemicals
39.8%$401M
KWRQuaker Chemical Corporation
FY 2025
Metalworking and Other
67.7%$1.3B
Metals
32.3%$611M
CBTCabot Corporation
FY 2025
Reinforcement Materials
65.2%$2.3B
Performance Chemicals
34.8%$1.3B
FULH.B. Fuller Company
FY 2025
Hygiene, Health, and Consumable Adhesives
44.7%$1.6B
Engineering Adhesives
30.6%$1.1B
Construction Adhesives
24.8%$860M

NGVT vs KWR vs CBT vs FUL — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCBTLAGGINGKWR

Income & Cash Flow (Last 12 Months)

NGVT leads this category, winning 4 of 6 comparable metrics.

CBT is the larger business by revenue, generating $3.6B annually — 3.0x NGVT's $1.2B. CBT is the more profitable business, keeping 8.0% of every revenue dollar as net income compared to NGVT's -10.6%. On growth, KWR holds the edge at +8.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNGVT logoNGVTIngevity Corporat…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationFUL logoFULH.B. Fuller Compa…
RevenueTrailing 12 months$1.2B$1.9B$3.6B$3.5B
EBITDAEarnings before interest/tax$378M$143M$731M$472M
Net IncomeAfter-tax profit-$128M$4M$285M$152M
Free Cash FlowCash after capex$246M$143M$459M$121M
Gross MarginGross profit ÷ Revenue+39.3%+34.4%+24.8%+31.5%
Operating MarginEBIT ÷ Revenue+22.8%+3.7%+15.7%+10.9%
Net MarginNet income ÷ Revenue-10.6%+0.2%+8.0%+4.4%
FCF MarginFCF ÷ Revenue+20.3%+7.4%+12.8%+3.5%
Rev. Growth (YoY)Latest quarter vs prior year-9.2%+8.5%-3.4%-3.1%
EPS Growth (YoY)Latest quarter vs prior year+196.4%+54.8%-23.1%+122.2%
NGVT leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

FUL leads this category, winning 3 of 6 comparable metrics.

At 14.6x trailing earnings, CBT trades at a 37% valuation discount to FUL's 23.1x P/E. On an enterprise value basis, CBT's 7.1x EV/EBITDA is more attractive than KWR's 12.0x.

MetricNGVT logoNGVTIngevity Corporat…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationFUL logoFULH.B. Fuller Compa…
Market CapShares × price$2.5B$2.5B$4.6B$3.4B
Enterprise ValueMkt cap + debt − cash$3.7B$3.3B$5.5B$5.4B
Trailing P/EPrice ÷ TTM EPS-15.61x-1031.86x14.56x23.14x
Forward P/EPrice ÷ next-FY EPS est.14.60x20.59x13.88x13.48x
PEG RatioP/E ÷ EPS growth rate7.45x
EV / EBITDAEnterprise value multiple10.05x12.03x7.14x9.28x
Price / SalesMarket cap ÷ Revenue2.17x1.33x1.23x0.99x
Price / BookPrice ÷ Book value/share87.73x1.83x2.79x1.76x
Price / FCFMarket cap ÷ FCF9.27x31.07x11.71x28.44x
FUL leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

CBT leads this category, winning 5 of 9 comparable metrics.

CBT delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-156 for NGVT. KWR carries lower financial leverage with a 0.67x debt-to-equity ratio, signaling a more conservative balance sheet compared to NGVT's 41.84x. On the Piotroski fundamental quality scale (0–9), FUL scores 7/9 vs KWR's 4/9, reflecting strong financial health.

MetricNGVT logoNGVTIngevity Corporat…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationFUL logoFULH.B. Fuller Compa…
ROE (TTM)Return on equity-156.1%+0.3%+16.8%+7.6%
ROA (TTM)Return on assets-7.3%+0.2%+7.4%+2.9%
ROICReturn on invested capital+14.2%+6.6%+17.4%+7.8%
ROCEReturn on capital employed+17.1%+7.6%+21.3%+9.2%
Piotroski ScoreFundamental quality 0–96467
Debt / EquityFinancial leverage41.84x0.67x0.71x1.01x
Net DebtTotal debt minus cash$1.2B$749M$957M$1.9B
Cash & Equiv.Liquid assets$78M$180M$258M$107M
Total DebtShort + long-term debt$1.2B$929M$1.2B$2.0B
Interest CoverageEBIT ÷ Interest expense-0.86x1.41x14.72x2.62x
CBT leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — NGVT and CBT each lead in 3 of 6 comparable metrics.

A $10,000 investment in CBT five years ago would be worth $15,582 today (with dividends reinvested), compared to $6,392 for KWR. Over the past 12 months, NGVT leads with a +66.6% total return vs FUL's +15.2%. The 3-year compound annual growth rate (CAGR) favors NGVT at 10.1% vs KWR's -9.2% — a key indicator of consistent wealth creation.

MetricNGVT logoNGVTIngevity Corporat…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationFUL logoFULH.B. Fuller Compa…
YTD ReturnYear-to-date+19.8%+4.7%+32.1%+6.2%
1-Year ReturnPast 12 months+66.6%+22.7%+17.4%+15.2%
3-Year ReturnCumulative with dividends+33.4%-25.1%+26.6%+1.5%
5-Year ReturnCumulative with dividends-10.8%-36.1%+55.8%-0.1%
10-Year ReturnCumulative with dividends+111.0%+77.9%+119.6%+50.6%
CAGR (3Y)Annualised 3-year return+10.1%-9.2%+8.2%+0.5%
Evenly matched — NGVT and CBT each lead in 3 of 6 comparable metrics.

Risk & Volatility

CBT leads this category, winning 2 of 2 comparable metrics.

CBT is the less volatile stock with a 0.82 beta — it tends to amplify market swings less than KWR's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 98.0% from its 52-week high vs KWR's 78.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNGVT logoNGVTIngevity Corporat…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationFUL logoFULH.B. Fuller Compa…
Beta (5Y)Sensitivity to S&P 5001.27x1.36x0.82x1.18x
52-Week HighHighest price in past year$79.05$183.00$89.46$68.63
52-Week LowLowest price in past year$39.74$111.32$58.33$48.71
% of 52W HighCurrent price vs 52-week peak+91.1%+78.9%+98.0%+92.7%
RSI (14)Momentum oscillator 0–10055.753.557.058.2
Avg Volume (50D)Average daily shares traded211K151K382K483K
CBT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CBT and FUL each lead in 1 of 2 comparable metrics.

Analyst consensus: NGVT as "Buy", KWR as "Buy", CBT as "Buy", FUL as "Buy". Consensus price targets imply 22.4% upside for KWR (target: $177) vs -1.9% for CBT (target: $86). For income investors, CBT offers the higher dividend yield at 2.02% vs KWR's 1.36%.

MetricNGVT logoNGVTIngevity Corporat…KWR logoKWRQuaker Chemical C…CBT logoCBTCabot CorporationFUL logoFULH.B. Fuller Compa…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$76.67$176.75$86.00$68.25
# AnalystsCovering analysts13141515
Dividend YieldAnnual dividend ÷ price+1.4%+2.0%+1.4%
Dividend StreakConsecutive years of raises181438
Dividend / ShareAnnual DPS$1.97$1.77$0.91
Buyback YieldShare repurchases ÷ mkt cap+2.2%+1.7%+3.7%+1.8%
Evenly matched — CBT and FUL each lead in 1 of 2 comparable metrics.
Key Takeaway

CBT leads in 2 of 6 categories (Profitability & Efficiency, Risk & Volatility). NGVT leads in 1 (Income & Cash Flow). 2 tied.

Best OverallCabot Corporation (CBT)Leads 2 of 6 categories
Loading custom metrics...

NGVT vs KWR vs CBT vs FUL: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is NGVT or KWR or CBT or FUL a better buy right now?

For growth investors, Quaker Chemical Corporation (KWR) is the stronger pick with 2.

7% revenue growth year-over-year, versus -17. 0% for Ingevity Corporation (NGVT). Cabot Corporation (CBT) offers the better valuation at 14. 6x trailing P/E (13. 9x forward), making it the more compelling value choice. Analysts rate Ingevity Corporation (NGVT) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NGVT or KWR or CBT or FUL?

On trailing P/E, Cabot Corporation (CBT) is the cheapest at 14.

6x versus H. B. Fuller Company at 23. 1x. On forward P/E, H. B. Fuller Company is actually cheaper at 13. 5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — NGVT or KWR or CBT or FUL?

Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +55.

8%, compared to -36. 1% for Quaker Chemical Corporation (KWR). Over 10 years, the gap is even starker: CBT returned +119. 6% versus FUL's +50. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NGVT or KWR or CBT or FUL?

By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.

82β versus Quaker Chemical Corporation's 1. 36β — meaning KWR is approximately 66% more volatile than CBT relative to the S&P 500. On balance sheet safety, Quaker Chemical Corporation (KWR) carries a lower debt/equity ratio of 67% versus 42% for Ingevity Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — NGVT or KWR or CBT or FUL?

By revenue growth (latest reported year), Quaker Chemical Corporation (KWR) is pulling ahead at 2.

7% versus -17. 0% for Ingevity Corporation (NGVT). On earnings-per-share growth, the picture is similar: Ingevity Corporation grew EPS 61. 1% year-over-year, compared to -102. 2% for Quaker Chemical Corporation. Over a 3-year CAGR, KWR leads at -1. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — NGVT or KWR or CBT or FUL?

Cabot Corporation (CBT) is the more profitable company, earning 8.

9% net margin versus -14. 3% for Ingevity Corporation — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NGVT leads at 22. 4% versus 9. 4% for KWR. At the gross margin level — before operating expenses — NGVT leads at 39. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is NGVT or KWR or CBT or FUL more undervalued right now?

On forward earnings alone, H.

B. Fuller Company (FUL) trades at 13. 5x forward P/E versus 20. 6x for Quaker Chemical Corporation — 7. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KWR: 22. 4% to $176. 75.

08

Which pays a better dividend — NGVT or KWR or CBT or FUL?

In this comparison, CBT (2.

0% yield), FUL (1. 4% yield), KWR (1. 4% yield) pay a dividend. NGVT does not pay a meaningful dividend and should not be held primarily for income.

09

Is NGVT or KWR or CBT or FUL better for a retirement portfolio?

For long-horizon retirement investors, Cabot Corporation (CBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

82), 2. 0% yield, +119. 6% 10Y return). Both have compounded well over 10 years (CBT: +119. 6%, NGVT: +111. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between NGVT and KWR and CBT and FUL?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NGVT is a small-cap quality compounder stock; KWR is a small-cap quality compounder stock; CBT is a small-cap deep-value stock; FUL is a small-cap quality compounder stock. KWR, CBT, FUL pay a dividend while NGVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.